Carvacrol (20 mg/kg/day) treatment significantly inhibited the changes of these signal proteins of the PI3K/AKT signaling pathway in the heart of mice with T1DM, compared with the vehicle-only treatment (Figures 6A, B, P < 0.05). This evidence concerns the gene AKT1 and type 1 diabetes mellitus.